Featured content
Strategies for scaling complex next-generation biologics
As biologic drug formats grow more sophisticated, scalable success depends on embedding manufacturability, analytics and quality thinking into molecular design from the very beginning of development.
ArticleRethinking the role of chemotherapy in haematology and oncology – reflections from EHA 2026
As chemotherapy use declines and targeted therapies assume a larger role in cancer treatment, researchers are looking beyond response rates to focus on real-world feasibility and reducing treatment burden for patients.
ArticleStrengthening regulatory consistency - why predictability matters rather more than speed
Regulatory predictability has become an increasingly important factor in determining where clinical development takes place. Drawing on lessons learned from delivering complex programmes across Europe, Regeneron’s Dr Muriel O’Byrne explores how greater consistency can help sponsors maximise value.
ArticleTo grow, pharma manufacturers need operations that scale - not just acquisitions
As patent cliffs threaten hundreds of billions in drug revenues and M&A activity reshapes the industry, the companies best placed to capitalise on pharma’s great reshuffling will be those that have standardised their manufacturing operations, unified their asset management and integrated quality systems capable of satisfying an increasingly demanding multi-regulator environment.
News
NewsChiesi advances carbon-minimal inhaler programme with European regulatory submissions
Chiesi advances its carbon-minimal inhaler programme with European regulatory submissions for next-generation HFA-152a pressurised metered-dose inhalers.
NewsPh. Eur. adopts new general chapter for phenolic antioxidant analysis
General chapter 2.5.46. introduces a single HPLC-UV method for simultaneous determination of seven plastic additives, streamlining compliance for pharmaceutical packaging materials.
NewsCPHI Pharma Awards 2026 finalists announced
Winners of this year’s awards will be revealed during the opening of CPHI Milan 2026.
NewsInternational parallel regulatory review aids acceleration of innovative manufacturing for LAL/rFc
Milestone shifts how global pharmaceutical manufacturers approach post-approval life cycle management for medicines.
From our partners
Closing the data integrity gap in pharmaceutical quality control
Pharmaceutical quality control laboratories face growing pressure to strengthen data integrity as regulators scrutinise incomplete records, manual data entry, and disconnected systems.
From passive to active air monitoring in aseptic filling: a risk-based approach to replacing settle plates
In this webinar, Particle Measuring Systems will share a case study of a biopharmaceutical company developing and applying a structured global rationale for the implementation of continuous viable environmental monitoring with a single-use microbial impactor within aseptic manufacturing environments.
Risks of non-compliance: managing impurity control and challenges with reference materials
Join USP to explore the latest approaches to organic impurity analysis and scientific solutions to support pharmaceutical quality, including regulatory expectations and practical applications of the USP Reference Standards.
Opinion and interviews
Real-time Raman spectroscopy closes bioprocess control measurement gap
Manual sampling cycles leave bioreactor control decisions hours behind culture dynamics. Process Raman spectroscopy offers continuous, real-time measurement of critical parameters, enabling true closed-loop control in perfusion and continuous bioprocessing applications where measurement lag directly impacts yield and product quality.
Process Raman spectroscopy: closing biomanufacturing’s measurement infrastructure gap
The biopharmaceutical industry has embraced Pharma 4.0 concepts, but the measurement infrastructure required to realise autonomous facilities and continuous bioprocessing remains underdeveloped. Process Raman spectroscopy offers continuous, non-destructive monitoring at frequencies aligned with cell culture dynamics, bridging the gap between control system capabilities and available data.
- Previous
- Next
Join now
Unlock exclusive industry insights
- Bookmark articles and resources to access anytime
- Enjoy free access to industry leading resources, webinars and insights
- Stay informed with the latest news and breakthroughs in drug discovery
- Receive updates and recommendations tailored to your research interests
Upcoming Webinars
Webinar
Regulatory shifts ahead: preparing for EU pharmaceutical reform and FDA changes
With the EU’s pharmaceutical legislation reform soon to come into force, regulatory experts outline what is changing across both US and European frameworks and how sponsors can position pipelines ahead of implementation.
Webinar
Risks of non-compliance: managing impurity control and challenges with reference materials
Join USP to explore the latest approaches to organic impurity analysis and scientific solutions to support pharmaceutical quality, including regulatory expectations and practical applications of the USP Reference Standards.
Webinar
Ensuring drug quality: mastering stability testing in pharma
Join this webinar to discover how UV-Vis spectroscopy and gas chromatography support API monitoring, testing and analysis.
Webinar
Modernising pharma QA/QC laboratories: preparing for a more connected, compliant future
Join this webinar to discover how modern QA/QC laboratories are embracing digital transformation to enhance compliance, workflows and data integrity to build a more connected, future-ready pharmaceutical quality ecosystem.
Webinar
From passive to active air monitoring in aseptic filling: a risk-based approach to replacing settle plates
In this webinar, Particle Measuring Systems will share a case study of a biopharmaceutical company developing and applying a structured global rationale for the implementation of continuous viable environmental monitoring with a single-use microbial impactor within aseptic manufacturing environments.
Regulatory shifts ahead: preparing for EU pharmaceutical reform and FDA changes
Risks of non-compliance: managing impurity control and challenges with reference materials
Ensuring drug quality: mastering stability testing in pharma
Modernising pharma QA/QC laboratories: preparing for a more connected, compliant future
From passive to active air monitoring in aseptic filling: a risk-based approach to replacing settle plates
On-demand Webinars
- Previous
- Next
